ceftizoxime

  • 网络头孢唑肟;头孢克肟;头孢肟唑;头孢噻肟、头孢唑肟;头孢去甲噻肟
ceftizoximeceftizoxime
  1. Study on the treatment of severe and difficult infections with ceftizoxime

    头孢唑肟治疗严重与难治性感染的临床研究

  2. Stability of ceftizoxime compatibility with six kinds of injection in transfusion

    头孢唑肟在输液中与6种注射剂配伍的稳定性研究

  3. Investigation of the compatible stability ceftizoxime sodium for injection in compound amino acid injection

    注射用头孢唑肟钠在复方氨基酸注射液中稳定性的研究

  4. A clinical study of ceftizoxime in the treatment of severe infections and gonorrhea

    头孢唑肟治疗重症和难治性感染及淋球菌感染的临床研究

  5. The dosage and route of administration of ceftizoxime in severe pulmonary infection

    头孢唑肟治疗重症肺部感染用药剂量和用药途径的探讨

  6. 61 cases of severe and difficult bacterial infections were treated with ceftizoxime .

    用头孢唑肟治疗严重与难治性细菌感染61例,其中肺部感染18例。

  7. Evaluation of the Efficacy of Ceftizoxime Sodium Intravenous Administration in Low Respiratory Tract Bacterial Infection

    注射用头孢唑肟钠治疗下呼吸道细菌感染的研究

  8. Comparing the Content of Ceftizoxime Sodium Injection by HPLC with that by Microorganisms

    HPLC与微生物法测定注射用头孢唑肟钠含量的比较

  9. Ceftizoxime Injection vs. Cefotaxime Injection for Lower Respiratory Tract Infection : Cost-effective Analysis

    注射用头孢唑肟和头孢噻肟治疗下呼吸道感染的成本-效果分析

  10. Observation on stability of compatibility between ceftizoxime sodium for injection and ribavirin injection

    注射用头孢唑肟钠与利巴韦林注射液配伍的稳定性考察

  11. Ceftizoxime therapy in severe infectious complications of hematological malignancies in 24 patients

    头孢唑肟治疗恶性血液病并发的重症感染24例

  12. Multicentre clinical study on ceftizoxime sodium intravenous injection for treatment of respiratory and urinary tract infection

    头孢唑肟钠注射剂治疗呼吸和泌尿系统感染多中心临床研究

  13. Conclusion Treatment low respiratory tract bacterial infections with injection ceftizoxime sodium ( made in China ) is safe and effective .

    结论注射用头孢唑肟钠(国产)治疗下呼吸道细菌感染安全有效。

  14. Pharmacokinetics and tissue concentration of ceftizoxime in dogs

    头孢唑肟在犬体内的组织浓度及药代动力学

  15. Comparison of ceftizoxime stability with other 14 β - lactams to β - lactamases

    比较头孢唑肟与其他14种β内酰胺类抗生素对β内酰胺酶的稳定性

  16. Aim : To study the synthesis of ceftizoxime alapivoxil analogues and to search for new-type prodrug of ceftizoxime .

    前言:目的:研究头孢唑肟丙匹酯类似物的合成,寻找新的头孢唑肟前药。

  17. Method : 86 cases of pneumonia patients were divided into the ceftizoxime sodium group and the cefuroxime sodium group . The cost-effectiveness relation was evaluated with the method of pharmacoeconomics cost-effectiveness analysis .

    方法:将86例肺炎患儿随机分为头孢唑肟钠治疗组和头孢呋辛钠治疗组,运用药物经济学的成本-效果分析方法进行比较。

  18. OBJECTIVE : To study the stability of ceftizoxime ( CZX ) mixed with vitamin B 6 etc. in 5 % glucose injection solution , and provide a scientific basis for rationalized use of CZX .

    目的:研究头孢唑肟(Ceftizoxime,CZX)在5%葡萄糖输液中与维生素B6等6种注射剂配伍的稳定性,为临床合理用药提供科学依据。

  19. Object evaluate the efficacy and the safety of ceftizoxime sodium intravenous administration ( made in China ) for treatment of low respiratory tract bacterial infection compared with Epocelin ( injection with ceftizoxime sodium , imported raw materials ) .

    目的以益保世灵(注射用头孢唑肟钠,进口原料)为对照,评价注射用头孢唑肟钠(国产)治疗下呼吸道细菌感染的疗效和安全性。

  20. Objective To compare the stability of ceftizoxime and other 14 β - lactams to β - lactamases , especially CTX-M type extended-spectrum β - lactamases and provide reference information for clinical rational choice of β - lactams .

    目的研究头孢唑肟对β内酰胺酶,特别是对CTX-M型超广谱酶的稳定性,并与临床常用β内酰胺抗生素比较。

  21. Clinical efficacy rate and bacterial eradication rate for cefotaxime was separately 85.25 % and 86.00 % . The incidence of adverse reaction including whole clinical reactions and laboratory abnormalities was 6.06 % for ceftizoxime group and 7.81 % for cefotaxime group .

    细菌清除率分别为85.19%和86.00%,药物不良反应发生率分别为6.06%和7.81%。

  22. Methods 42 cases of low respiratory tract bacterial infection patients randomly divided into two groups ( observer group and control group ), the observer group was administrated ceftizoxime sodium ( made in China ) and control group was administrated Epocelin , regimens 7 ~ 14 days .

    方法42例下呼吸道细菌感染患者随机分入观察组和对照组,观察组给予注射用头孢唑肟钠粉针剂(国产)治疗,对照组给予益保世灵治疗,疗程7~14天。